All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for ELEVANCE HEALTH, INC. · Health Benefits Provider

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $90,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 4

Pharmacy

Prescription Drug Pricing.

Taxation/Internal Revenue Code

Issues related to advanced premium tax credits. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14.

Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14.

Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.